# Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002

> **NCT01338935** · PHASE1 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 136 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CW 002
- **DRUG:** CW 002
- **DRUG:** CW 002

## Key facts

- **NCT ID:** NCT01338935
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 136 (ACTUAL)
- **Why stopped:** Pharmacokinetic stopping criteria for the study were met.
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01338935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01338935, "Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01338935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*